Clinical Trials Directory

Trials / Conditions / Hormone Receptor Positive / HER2-negative Breast Cancer

Hormone Receptor Positive / HER2-negative Breast Cancer

8 registered clinical trials studyying Hormone Receptor Positive / HER2-negative Breast Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
NCT07101159
Fujian Cancer HospitalPhase 2
RecruitingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan
NCT06805812
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano—
UnknownSelect the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
NCT05809024
Yongsheng WangPhase 4
RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
GenmabPhase 1 / Phase 2
WithdrawnA Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select
NCT05234606
Silverback TherapeuticsPhase 1 / Phase 2
CompletedA Study of PRT2527 in Participants With Advanced Solid Tumors
NCT05159518
Prelude TherapeuticsPhase 1
Active Not RecruitingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Express
NCT04802876
SOLTI Breast Cancer Research GroupPhase 2
CompletedONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
NCT03394027
National Cancer Institute (NCI)Phase 2